₩102700.00
₩-400.00 (-0.39%)
End-of-day quote: 05/17/2024
KOSE:A185750
Chong Kun Dang Pharmaceutical Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
₩1.67T | ₩1.49T | ₩1.34T | ₩1.30T | ₩1.08T | ₩956.22B | ₩884.36B | ₩831.99B | ₩0.00M | ₩0.00M | |
| GM % | Gross Margin % |
|
39.67% | 36.46% | 36.90% | 37.54% | 37.46% | 39.78% | 40.67% | 40.25% | 0.00% | 0.00% | |
| OM | Operating Margin |
|
14.77% | 7.38% | 7.05% | 9.51% | 6.91% | 7.92% | 8.79% | 7.36% | 0.00% | 0.00% | |
| EPS | Earnings Per Share |
|
₩0.00 | ₩15.39k | ₩6.77k | ₩3.17k | ₩7.08k | ₩4.30k | ₩3.39k | ₩4.26k | ₩3.09k | ₩-511.69 | ₩2.66k |
| Div. | Dividends |
|
₩925.06 | ₩952.38 | ₩907.03 | ₩822.70 | ₩740.43 | ₩705.17 | ₩671.59 | ₩639.61 | ₩426.41 | ₩568.55 | |
| PR % | Payout Ratio % |
|
6.01% | 14.06% | 28.63% | 11.62% | 17.22% | 20.78% | 15.78% | 20.67% | -83.33% | 21.40% | |
| Sha. | Shares |
|
12.73m | 12.19m | 11.8m | 11.92m | 11.36m | 10.83m | 10.89m | 11.43m | 11.44m | 11.44m | |
| OCF | Operating Cash Flow |
|
₩318.16B | ₩67.73B | ₩12.90B | ₩104.32B | ₩77.29B | ₩42.63B | ₩81.67B | ₩57.79B | ₩0.00M | ₩0.00M | |
| FCF | Free Cash Flow |
|
₩172.52B | ₩19.34B | ₩-32941.72M | ₩74.60B | ₩60.72B | ₩27.46B | ₩68.83B | ₩19.86B | ₩-24961.99M | ₩45.85B | |
| FCFS | Free Cash Flow Per Share |
|
₩19.60k | ₩1.20k | ₩-3286.01 | ₩5.66k | ₩4.84k | ₩1.58k | ₩5.57k | ₩1.71k | ₩0.00 | ₩0.00 |
